It was observed that the level of liver PGE2 and the expression of EP2, EP4, CXCL1 were significantly reduced by antifungal treatments (Figure 4e-h), accompanying with the amelioration on the hepatic steatosis (Figure S2B-D). This evidence concerns the gene CXCL1 and fatty liver disease.